Advanced Technology-based Rehabilitation Post-stroke Gait Re-learning
1 other identifier
observational
80
1 country
1
Brief Summary
High-tech therapy, an innovative field of neurorehabilitation, has expanded rapidly in recent years. Advances in technology have enabled the use of devices that can assist with movement development from simple movements to more complex tasks. This research investigates the effectiveness of rehabilitation programmes that complement robot-assisted therapy to help people relearn to walk in post-stroke rehabilitation. This would be measured in two variations, with the patient (in addition to a complex rehabilitation programme of conventional physiotherapy, occupational therapy, hydrotherapy, etc.) receiving either treadmill or no treadmill treatment. In both cases, the therapies will be carried out with advanced technology-based equipment (both treatments are part of the daily routine of the Institute's treatments, and the equipment will be used according to the instructions in the user manual), the C-Mill interactive robot-assisted device will be used for treadmill therapy, and the Andago robot-assisted device for non- treadmill therapy. There is no sharp distinction between the two systems. The inclusion and exclusion criteria are set so patients' conditions meet the indications for both devices, and patients eligible for treatment with one device are included in the other. In our study, 80 patients will be selected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
April 3, 2024
CompletedFirst Posted
Study publicly available on registry
July 11, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 11, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 12, 2026
CompletedMarch 4, 2026
March 1, 2026
2.1 years
April 3, 2024
March 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (15)
Balancing skills
Berg Balance Test (values between 0-56, higher score means better outcome).
Through study completion, an average of 2 years.
Balancing skills
Timed Up and Go Test (how many seconds it takes the patient to complete the task).
Through study completion, an average of 2 years.
Balancing skills
Weight distribution (%) using the DIERS medical device.
Through study completion, an average of 2 years.
Balancing skills
COP movement (mm) using the DIERS medical device.
Through study completion, an average of 2 years.
Balancing skills
Sway area (mm2) using the DIERS medical device.
Through study completion, an average of 2 years.
Balancing skills
Romberg opened eyes, closed eyes (mm) using the DIERS medical device.
Through study completion, an average of 2 years.
Balancing skills
Strength of the lower limbs (hip extension, flexion, adduction and abduction) and the trunk (flexion, extension, rotation, lateroflexion) (N) using the DIERS medical device.
Through study completion, an average of 2 years.
Gait parameters
6-minute gait test (m).
Through study completion, an average of 2 years.
Gait parameters
10-meter gait test (min).
Through study completion, an average of 2 years.
Gait parameters
step length (mm), using the DIERS medical device.
Through study completion, an average of 2 years.
Gait parameters
Step width (mm), using the DIERS medical device.
Through study completion, an average of 2 years.
Gait parameters
Heel strike (N), using the DIERS medical device.
Through study completion, an average of 2 years.
Gait parameters
COP movement (mm), using the DIERS medical device.
Through study completion, an average of 2 years.
Functional independence
Based on FIM (maximum 126 points, higher score means better outcome).
Through study completion, an average of 2 years.
Functional independence
Based on Barthel (values between 0-99, higher score means better outcome).
Through study completion, an average of 2 years.
Study Arms (2)
Treadmill group
In both groups, using advanced technology-based tools (both treatments are part of the daily routine of the Institute's treatments and are used according to the instructions in the user manual), for the treadmill therapy, we use the C-Mill interactive high-tech device.
Overground group
In both groups, we use an advanced technology-based device (both treatments are part of the daily routine of the Institute's treatments and are used according to the instructions in the user manual), and the Andago high-tech device for non-runner therapy.
Interventions
Therapy using an advanced technological device enables exercise on the ground.
The examination starts and ends with the DIERS motion analysis system, a light-optical scanning method based on VRS (Video Raster Stereography) and a sensor-equipped treadmill that allows the measurement of several parameters of gait and balancing ability.
Traditional physiotherapy assessment methods (Timed Up and Go, Berg Balance Test, 6-minute gait test, 10-metre gait test, Functional Independence Measure, Barthel) are used to assess gait pattern and self-sufficiency.
Eligibility Criteria
Patients of the National Institute for Medical Rehabilitation, Budapest, Hungary
You may qualify if:
- Hemiparetic patient who has had a stroke;
- ischaemic or haemorrhagic stroke confirmed by CT or MRI;
- female or male between 40 and 75 years of age;
- subgroup 1: less than 3 months since stroke,
- subgroup 2: more than 3 months but less than 1 year since stroke;
- physical fitness adequate for the exertion of the treatment;
- right or left lower limb involvement;
- score 3 on the Functional Ambulation Categories (FAC) scale, i.e. Indicates a patient who can ambulate on a level surface without manual contact of another person but requires standby guarding of one person either for safety or verbal cueing;
- or score 4 on the Functional Ambulation Categories (FAC) scale, i.e. Indicates a patient who can ambulate independently on a level surface but requires supervision to negotiate (e.g. stairs, inclines, non-flat surfaces);
- be able to participate in therapy and cooperate based on cognitive function;
- signed informed consent.
You may not qualify if:
- More than 1 year has passed since the stroke;
- scores less than or equal to 3 on the Functional Ambulation Categories (FAC) scale;
- patients who were unable to walk independently before the stroke;
- patients treated with botulinum toxin in the lower limb in the last 3 months;
- use of other lower limb advanced technology treatments during the study;
- a person with limited capacity;
- not physically able to bear weight;
- severe aphasia (impairment of understanding or expression that severely impedes communication);
- other condition that precludes the use of C-Mill or Andago:
- severe emotional disturbance;
- mentally incapacitated patient;
- severe contracture or spasticity preventing the patient from being placed in the machine;
- pregnancy;
- skin disease in the area of contact with the straps;
- fever;
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institute for Medical Rehabilitation
Budapest, Pest County, 1121, Hungary
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gábor Fazekas, MD, PhD
National Institute for Medical Rehabilitation, Hungary
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 3, 2024
First Posted
July 11, 2024
Study Start
January 1, 2024
Primary Completion
February 11, 2026
Study Completion
February 12, 2026
Last Updated
March 4, 2026
Record last verified: 2026-03